Four blue states are asking the U.S. Food and Drug Administration to remove restrictions on a key abortion medication and make it easier for clinicians to prescribe and dispense it - an attempt to widen access as the agency plans to review the pill’s safety.

The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on mifepristone given its “25-year safety record.”